David M. Kent

An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke

David M. Kent, Robin Ruthazer, Christian Weimar et al. · Neurology · 2013 · 603 citations · Full text

Limitations of Applying Summary Results of Clinical Trials to Individual Patients

David M. Kent, Rodney A. Hayward · JAMA · 2007 · 493 citations

Individual Patients, Clinical Endpoint, Otorhinolaryngology +19

Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal

David M. Kent, Peter M. Rothwell, John P. A. Ioannidis et al. · Trials · 2010 · 481 citations · Full text

The Predictive Approaches to Treatment effect Heterogeneity (PATH) Statement

David M. Kent, Jessica K. Paulus, David van Klaveren et al. · Annals of Internal Medicine · 2019 · 379 citations · Full text

Patient Selection, Treatment Effect, Quasi-experiment +19

Three simple rules to ensure reasonably credible subgroup analyses

James Burke, Jeremy B. Sussman, David M. Kent et al. · BMJ · 2015 · 299 citations · Full text